FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Versatis 5% medicated plasters (Grunenthal Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Lidocaine 5% medicated plasters 10 plaster Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Versatis 5% medicated plasters (Grunenthal Ltd) 30 plaster 6 x 5 plasters Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Versatis 5% medicated plasters (Grunenthal Ltd) 10 plaster 2 x 5 plasters Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Nycomed (UK) Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours patches 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) 8 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (DE Pharmaceuticals) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 15micrograms/hour transdermal patches (DE Pharmaceuticals) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (DE Pharmaceuticals) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 15micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (DE Pharmaceuticals) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (DE Pharmaceuticals) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches (Imported) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches (Imported) 1 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches (A A H Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches (A A H Pharmaceuticals Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 7mg/24hours transdermal patches (Pierre Fabre Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 21mg/24hours transdermal patches (Pierre Fabre Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 7mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 14mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicopatch 21mg/24hours transdermal patches (Pierre Fabre Ltd) 7 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) 30 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 25micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 50micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 75micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 100micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 12micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 25micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 50micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 75micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentalis Reservoir 100micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 12micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Sandoz Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 1mg/72hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 21mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 10mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 15mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 37.5micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 40micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 75micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 100micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 4 of 21 Next End

This concept is not in any reference sets

Back to Start